Inhibition of GH3 and HEK293 pituitary adenoma cell growth by Trigonella foenum-graecum extract (TFGE) via mTORC1 down-regulation

References

• Alizadeh S, Jahanmehr SA, Ardjmand AR, Rezian M, Dargahi H, Einolahi N, Sadrossadat, M. 2009. Antineoplastic effect of fenugreek (Trigonella foenum graecum) seed extract against acute myeloblastic leukemia cell line (KG-1) Iran. J Blood Cancer. 1:139–146.
   Google Scholar
• Armengol G, et al. 2007. 4E-binding protein 1: A key molecular “funnel factor” in human cancer with clinical implications. Cancer Res 67:7551–7555.
   PubMed Web of Science ®Google Scholar
• Bevan JS, Webster J, Burke CW, Scanlon MF. 1992. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13:220–240.
   PubMed Web of Science ®Google Scholar
• Chen R, et al. 2017. mTOR promotes pituitary tumor development through activation of PTTG1. Oncogene. 36:979–988.
   PubMed Web of Science ®Google Scholar
• Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J. 2008. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA. 105:17414–17419.
   PubMed Web of Science ®Google Scholar
• Dowling RJ, et al. 2010. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science. 328:1172–1176.
   PubMed Web of Science ®Google Scholar
• Dunlop EA, Hunt DK, Acosta-Jaquez HA, Fingar DC, Tee AR. 2014. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy. 7:737–747.
   Google Scholar
• Field JK, Spandidos DA. 1990. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res. 10:1–22.
   PubMed Web of Science ®Google Scholar
• Gao Y, et al. 2014. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res 42:13799–13811.
   PubMed Web of Science ®Google Scholar
• Gillam MP, Molitch ME, Lombardi G, Colao A. 2006. Advances in the treatment of prolactinomas. Endocr Rev 27:485–534.
   PubMed Web of Science ®Google Scholar
• Gupta P, Tripathi M, Dhandapani S, Dutta P. 2020. India’s march towards development of treatment for pituitary tumors. Neurol India. 68:1183–1187.
   Web of Science ®Google Scholar
• Han G, Wang Y, Bi W. 2012. C–Myc overexpression promotes osteosarcoma cell invasion via activation of MEK–ERK pathway. Oncol Res. 20:149–156.
   PubMed Web of Science ®Google Scholar
• Hara K, et al. 2002. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 110:177–189.
   PubMed Web of Science ®Google Scholar
• Hausch F, Kozany C, Theodoropoulou M, Fabian AK. 2013. FKBPs and the Akt/mTOR pathway. Cell Cycle. 12:2366–2370.
   PubMed Web of Science ®Google Scholar
• Holz MK, Ballif BA, Gygi SP, Blenis J. 2005. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell. 123:569–580.
   PubMed Web of Science ®Google Scholar
• Kokontis J, Takakura K, Hay N, Liao S. 1994. Increased androgen receptor activity and altered c–myc expression in prostate cancer cells after long–term androgen deprivation. Cancer Res. 54:1566–1573.
   PubMed Web of Science ®Google Scholar
• Kulkarni CP, Bodhankar SL, Ghule AK, Mohan V, Thakurdeai PA. 2012. Antidiabetic activity of Trigonella foenum graecum L. seeds extract in neonatal streptocotocin-induced (N-STZ) rats. Diabetol Croat. 41:29–40.
   Google Scholar
• Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell. 149:274–293.
   PubMed Web of Science ®Google Scholar
• Lee M, et al. 2015. Targeting PI3 K/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas. Clin Cancer Res 21:3204–3215.
   Web of Science ®Google Scholar
• Li N, et al. 2017. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.J Clin Invest. 127:1284–1302.
   PubMed Web of Science ®Google Scholar
• Lin HP, Lin CY, Liu CC, Su LC, Huo C, Kuo YY, Tseng JC, Hsu JM, Chen CK, Chuu CP. 2013. Caffeic acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. Int J Mol Sci. 14:5264–5283.
   PubMed Web of Science ®Google Scholar
• Liu CC, Hsu JM, Kuo LK, Chuu CP. 2013. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Med Hypotheses. 80:617–619.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang G, Li J, Liu J, Lv P. 2014. The tumor–suppressive microRNA–135b targets c–myc in osteoscarcoma. PLoS One. 9:e102621.
   Web of Science ®Google Scholar
• Magnuson B, Ekim B, Fingar DC. 2012. Regulation and function of ribosomal protein S6 kinase (S6 K) within mTOR signalling networks. Biochem J. 441:1–21.
   PubMed Web of Science ®Google Scholar
• Melmed S. 2011. Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7:257–266.
   PubMed Web of Science ®Google Scholar
• Moerke NJ, et al. 2007. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell. 128:257–267.
   PubMed Web of Science ®Google Scholar
• Mohan CD, Srinivasa V, Rangappa S, Mervin L, Mohan S, Paricharak S, Baday S, Li F, Shanmugam MK, Chinnathambi A, et al. 2016. Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3 K/Akt/mTOR signaling pathway. PLoS One. 11(4):e0153155.
   PubMed Web of Science ®Google Scholar
• Ni J, et al. 2016. Combination inhibition of PI3 K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2- positive breast cancer brain metastases. Nat Med 22:723–726.
   Web of Science ®Google Scholar
• Ong PS, Wang LZ, Dai X, Tseng SH, Loo SJ, Sethi G. 2016. Judicious toggling of mTOR activity to combat Insulin resistance and cancer: current evidence and perspectives. Front Pharmacol. 7(25):395.
   Google Scholar
• Pandian RS, Anuradha CV, Viswanathan P. 2002. Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats. J Ethnopharmacol. 81:393–397.
   PubMed Web of Science ®Google Scholar
• Popova NV, Jücker M. 2021. The role of mTOR signaling as a therapeutic target in cancer. Int J Mol Sci. 22(4):1743.
   PubMed Web of Science ®Google Scholar
• Rodrik-Outmezguine VS, et al. 2011. mTOR kinase inhibition causes feedbackdependent biphasic regulation of AKT signaling. Cancer Discov. 1:248–259.
   PubMed Web of Science ®Google Scholar
• Rojo F, et al. 2007. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 13:81–89.
   PubMed Web of Science ®Google Scholar
• Saxton RA, Sabatini DM. 2017. mTOR signaling in growth, metabolism, and disease. Cell. 168:960–976.
   PubMed Web of Science ®Google Scholar
• Schalm SS, Fingar DC, Sabatini DM, Blenis J. 2003. TOS motif-mediated Raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol. 13:797–806.
   PubMed Web of Science ®Google Scholar
• She QB, et al. 2010. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell. 18:39–51.
   PubMed Web of Science ®Google Scholar
• Subhashini N, Thangathirupathi A, Lavanya N. 2011. Antioxidant activity of Trigonella foenum greacum using various in vitro and ex vivo models. Int J Pharm Pharm Sci. 3:96–102.
   Google Scholar
• Taniguchi PK, Andonegui ES, Peña ME, et al. 2020. Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep. 10:19373.
   Web of Science ®Google Scholar
• Wang L, Harris TE, Roth RA, Jr LJ. 2007. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem. 282:20036–20044.
   PubMed Web of Science ®Google Scholar
• Yan L, et al. 2015. Regulation of tumor cell migration and invasion by the H19/let-7axis is antagonized by metformin-induced DNA methylation. Oncogene. 34:3076–3084.
   PubMed Web of Science ®Google Scholar
• Ze RW, Lichong Y, Yan TL, Lei C, Yu HG, Yong Z, Hong Y, Lin C, Han BS, Wei WR, et al. 2018. Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/raptor interaction in pituitary tumours. Nat Commun. 9:4624.
   Web of Science ®Google Scholar
• Zhang A, He S, Sun X, Ding L, Bao X, Wang N. 2014. Wnt5a promotes migration of human osteosarcoma cells by triggering a phosphatidylinositol–3 kinase/Akt signals. Cancer Cell Int. 14:15.
   PubMed Web of Science ®Google Scholar
• Zhou J, et al. 2015. H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nat Commun 6:10221.
   PubMed Web of Science ®Google Scholar